预测结直肠癌的死亡率和复发:对预测模型的比较评估
Shayeste Alinia1, Mohammad Asghari-Jafarabadi2, Leila Mahmoudi1
1Department of Statistics and Epidemiology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Heliyon
|March 22, 2024
概括
这项研究评估了结直肠癌 (CRC) 死亡率和复发的预测模型. 增强模型在预测死亡率方面表现出色,而渐变增强在CRC患者的复发预测方面表现出色.
科学领域:
- 在瘤学瘤学.
- 机器学习 机器学习
- 生物统计学 生物统计学
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症死亡的主要原因.
- 准确预测CRC死亡率和复发对于患者管理至关重要.
研究的目的:
- 评估各种机器学习模型对结直肠癌死亡率的预测准确度.
- 评估这些模型在预测CRC患者疾病复发方面的表现.
主要方法:
- 在2001年至2017年期间诊断的284名CRC患者的回顾性分析.
- 评估决策树,随机森林,随机生存森林 (RSF),梯度提升, mboost,深度学习神经网络 (DLNN) 和Cox回归模型.
- 性能指标包括灵敏度,特异性,正预测值 (PPV),ROC区域和整体准确性.
主要成果:
- 对于死亡率预测, mboost 实现了最高准确度 (89%),灵敏度为 96.9%,ROC 面积为 0.88. 随机森林显示了100%的灵敏度,但0%的特异性.
- 渐变增强在复发预测方面表现出卓越的性能,具有100%的灵敏度,92.9%的特异性和96.4%的ROC面积.
- 在所有评估的指标中,DLNN模型在死亡率和复发预测方面表现不佳.
结论:
- 博斯特模型在预测结直肠癌患者的死亡率方面非常有效.
- 渐变增强显示出在CRC中预测复发的绝佳潜力.
- 这些发现凸显了特定机器学习模型在改善结直肠癌预后准确性的实用性.
相关概念视频
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Comparing the Survival Analysis of Two or More Groups
181
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
181
Kaplan-Meier Approach
136
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
136
Receiver Operating Characteristic Plot
154
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
154
Actuarial Approach
77
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
77
Assumptions of Survival Analysis
126
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
126


